R&D/ Views & Analysis/ Views and analysis Targeting COVID-19 and cancer with immunotherapy advancements mike.hammerton@pharmaphorum.com : Anna Biosciences, cancer, COVID-19, immuno-oncology, immunotherapy, Oncology 0 Comment Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform. Over the last 30 years, we Share X Targeting COVID-19 and cancer with immunotherapy advancements https://pharmaphorum.com/r-d/targeting-covid-19-cancer-immunotherapy-advancements/